These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12617437)

  • 1. The incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit.
    Hussain M; Earley MJ
    Ir Med J; 2003 Jan; 96(1):18-20. PubMed ID: 12617437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit.
    Kumar P; Orton CI; McWilliam LJ; Watson S
    Br J Plast Surg; 2000 Oct; 53(7):563-6. PubMed ID: 11000071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal cell carcinomas: do they need to be followed up?
    Park AJ; Strick M; Watson JD
    J R Coll Surg Edinb; 1994 Apr; 39(2):109-11. PubMed ID: 7520063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases.
    Farhi D; Dupin N; Palangié A; Carlotti A; Avril MF
    Dermatol Surg; 2007 Oct; 33(10):1207-14. PubMed ID: 17903153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up of basal cell carcinomas: an audit of current practice.
    Mc Loone NM; Tolland J; Walsh M; Dolan OM
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):698-701. PubMed ID: 16836498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incomplete primary excision of cutaneous basal and squamous cell carcinomas in the Bay of Plenty.
    Talbot S; Hitchcock B
    N Z Med J; 2004 Apr; 117(1192):U848. PubMed ID: 15107870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit.
    Meek MF; Coert JH; Barret-Nerin J
    Br J Plast Surg; 2001 Mar; 54(2):183-4. PubMed ID: 11207145
    [No Abstract]   [Full Text] [Related]  

  • 8. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors contributing to incomplete excision of nonmelanoma skin cancer by Australian general practitioners.
    Hansen C; Wilkinson D; Hansen M; Soyer HP
    Arch Dermatol; 2009 Nov; 145(11):1253-60. PubMed ID: 19917954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of incomplete facial Basal cell carcinoma excision.
    Shah SA; Obaidullah ; Fahimullah
    J Coll Physicians Surg Pak; 2005 Mar; 15(3):149-51. PubMed ID: 15808092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Audit of histologically incompletely excised basal cell carcinomas: recommendations for management by re-excision.
    Griffiths RW
    Br J Plast Surg; 1999 Jan; 52(1):24-8. PubMed ID: 10343586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
    Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
    Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eyelid basal cell carcinoma: non-Mohs excision, repair, and outcome.
    Hamada S; Kersey T; Thaller VT
    Br J Ophthalmol; 2005 Aug; 89(8):992-4. PubMed ID: 16024851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
    Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
    J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas. Associated risk factors and preferred surgical management.
    Codazzi D; Van Der Velden J; Carminati M; Bruschi S; Bocchiotti MA; Di Serio C; Barberis M; Robotti E
    J Plast Surg Hand Surg; 2014 Feb; 48(1):38-43. PubMed ID: 23731130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low 5-year recurrence rate after surgical excision of 126 basal cell carcinomas with frozen section analysis upon indication].
    van der Meer GT; Willemse F; Marck KW
    Ned Tijdschr Geneeskd; 2001 Jul; 145(29):1409-13. PubMed ID: 11494691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do basal cell carcinomas recur after complete conventional surgical excision?
    Griffiths RW; Suvarna SK; Stone J
    Br J Plast Surg; 2005 Sep; 58(6):795-805. PubMed ID: 16086990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential, oncologically adequate therapy of basalioma].
    Germann G; Bernstein-Sommer B; Petrovici V; Steinau HU
    Handchir Mikrochir Plast Chir; 1992 May; 24(3):151-8. PubMed ID: 1618421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological variation of incompletely excised basal cell carcinoma's and the variation with the grade of surgeon - implications for revalidation.
    Robinson AJ; Walsh M; Hill C
    Eur J Surg Oncol; 2015 Jan; 41(1):165-8. PubMed ID: 25468457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it really necessary to make wide excisions for basal cell carcinoma treatment?
    Unlü RE; Altun S; Kerem M; Koç MN
    J Craniofac Surg; 2009 Nov; 20(6):1989-91. PubMed ID: 19881375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.